Autoantibodies to extractable nuclear antigens: Making detection and interpretation more meaningful

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 1, 2002, Pages 1-7

  Tri, Giang Phan ^a   Wong, Richard C W ^a   Adelstein, Stephen ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN;

ALGORITHM; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; COUNTER IMMUNOELECTROPHORESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; LABORATORY TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; TREATMENT INDICATION;

ANTIGENS, NUCLEAR; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NUCLEAR PROTEINS;

EID: 0036145903     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.1.1-7.2002     Document Type: Short Survey

References (39)

1. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: A collaborative study with the biomedical industry
2. Anti-SSA/Ro antibody determination by enzyme-linked immunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening
3. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein
4. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens
5. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases: 1989-1992
6. Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation
7. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus
8. Development of the antinuclear and anticytoplasmic antibody consensus panel by the Association of Medical Laboratory Immunologists
9. Clinical significance and cost-effectiveness of clinical immunology testing
10. Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis
11. Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?
12. Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: Their specificity and inter-relations in connective tissue disease sera
13. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera
14. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: Comparison of five methods
15. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders
16. The detection of anti-Ro/SS-A and anti-La/SS-B antibodies. A comparison of counterimmunoelectrophoresis with immunoblot, ELISA, and RNA-precipitation assays
17. High-quality, cost-effective strategy for detection of autoantibodies to extractable nuclear antigens
18. Evaluation of a line immunoblot assay for detection of antibodies recognizing extractable nuclear antigens
19. Use of methodological standards in diagnostic test research. Getting better but still not good
20. Different strategies in the laboratory diagnosis of autoimmune disease: Immunofluorescence, enzyme-linked immunosorbent assay or both?
21. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus
22. Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and Western blotting
23. Recombinant autoantigens
24. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians
25. The 1982 revised criteria for the classification of systemic lupus erythematosus
26. Range of antinuclear antibodies in "healthy-"individuals
27. Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La
28. Immunoprecipitation of labelled proteins
29. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity
30. Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells?
31. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice
32. Technical problems concerning the use of immunoblots for the detection of antinuclear antibodies
33. A comparison of ELISA assays as routine diagnostic test for detection of autoantibodies against extractable nuclear antigens
34. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases
35. Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and systemic lupus erythematosus
36. Counterimmunoelectrophoresis with serum prediffusion: An improved method for the detection and identification of antibodies against extractable nuclear and cytoplasmic antigens
37. The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods
38. The use of Tween 20 in immunoblotting assays for the detection of autoantibodies in connective tissue diseases